1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow TRAF3IP2 protein, human: new trials by email Literature Review of TRAF3IP2 protein, human trials Research Report on TRAF3IP2 protein, human
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Safety, Tolerability and Efficacy of iNexin™ for the Treatment of the Signs and Symptoms Associated With Dry Eye Disease iNexin™ (0.08% aCT1), iNexin™ (0.4% aCT1), iNexin™ (2.0% aCT1) - Dry Eye Disease | Phase 1 | Completed | Xequel Bio, Inc. | 30 | 2021-09-28 | 2022-03-04 |
Xequel Bio, Inc. (1)
United States (1)